Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System-MedSci.cn

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

Wang, TS; Lu, WC; Tang, HL; Buse, JB; Sturmer, T; Gower, EW

Wang, TS (reprint author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.

DIABETES CARE, 2019; 42 (2): E21